As Senior Vice President and Chief Medical Officer for Humana, Dr. Roy Beveridge is responsible for developing and implementing the company’s clinical strategy and advancing its integrated care delivery model.
Dr. Beveridge is known for creating collaborative environments among physician communities and providing thought leadership around population health. He is a member of Humana’s Management Team, which sets the strategic direction for the company.
Previously, Dr. Beveridge served as Chief Medical Officer for McKesson Specialty Health, a Dallas-based subsidiary of McKesson Inc. Prior to McKesson’s acquisition of US Oncology in 2010, he served as the Executive Vice President and Medical Director at US Oncology. Dr. Beveridge also was the Co-Director of the Bone Marrow Transplant Program at INOVA Fairfax Hospital in Falls Church, Virginia. He has published extensively in the fields of medical oncology, quality design and population health.
Dr. Beveridge earned a Bachelor of Arts degree from Johns Hopkins University and a medical degree from Cornell University Medical College. He completed his residency in internal medicine at University of Chicago Hospitals and his fellowship at Johns Hopkins Hospital.
Board certified in medical oncology and internal medicine, Dr. Beveridge has authored numerous articles on a wide range of medical topics such as hematology, stem cell transplantation and quality/value-based medical practice.
Dr. Beveridge is a member of the American Medical Association, American Society of Clinical Oncology (ASCO) and the American Society of Hematology. Previously, he has served on many boards related to medical oncology and patient advocacy.